Notoginsenoside R1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via ERα/GSK‐3β/β‐catenin signalling pathway

International Journal of Experimental Pathology · Published 2023-10-30 · DOI 10.1111/iep.12494

Authors being retrieved — see the publisher record. https://doi.org/10.1111/iep.12494

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2023

Related articles

• Zinc transporter ZnT5 is associated with epithelial mesenchymal transition via SMAD1 in breast cancer · International Journal of Experimental Pathology · 2024 · Same journal
• Thrombospondins: Conserved mediators and modulators of metazoan extracellular matrix · International Journal of Experimental Pathology · 2024 · Same journal
• British Society for Matrix Biology Spring Meeting 2023: Vascular Inflammation and the Extracellular Matrix · International Journal of Experimental Pathology · 2023 · Same journal
• Perinatal exposure to lead alters male reproductive behaviour and immunoreactivity of androgen and oestrogen receptors in the brain · International Journal of Experimental Pathology · 2024 · Same journal
• Determination of osteopontin in monitoring retinal damage in metabolic syndrome · International Journal of Experimental Pathology · 2024 · Same journal
• MiR‐22‐3p facilitates bone marrow mesenchymal stem cell osteogenesis and fracture healing through the SOSTDC1‐PI3K/AKT pathway · International Journal of Experimental Pathology · 2023 · Same journal
• Exploring effect of M2 macrophages on experimental full‐thickness wound healing in streptozotocin‐induced diabetic rats · International Journal of Experimental Pathology · 2023 · Same journal
• The frequency of dysplastic branching crypts in colorectal polypoid tubular adenomas · International Journal of Experimental Pathology · 2023 · Same journal
• British Society for Matrix Biology Spring Meeting 2024: The Dynamic matrix—Mechanics, Ageing and Repair · International Journal of Experimental Pathology · 2024 · Same journal
• Arginine vasopressin deficiency and conivaptan (a V1a–V2 receptor antagonist) treatment reverses liver damage and fibrosis in rats with chronic portocaval anastomosis · International Journal of Experimental Pathology · 2023 · Same journal